Harrick Plasma is excited to partner with FesariusTherapeutics Inc., maker of DermiSpere™, a dermal regeneration scaffold that promises game-changing efficacy in a $5 billion addressable market. DermiSphere utilizes patented collagen microsphere hydrogel technology invented at Weill Cornell by company co-founder Dr. Jason Spector, a practicing plastic and reconstructive surgeon and founder of the Laboratory for Bioregenerative Surgery and Medicine at Weill Cornell, where Fesarius’ underlying technology was developed. Fesarius recently received a Small Business Innovation Research (SBIR) Phase I award and expects to apply for FDA 510K clearance by December 2020.

In its manufacturing process for DermiSphere™, Fesarius utilizes the Harrick Plasma Expanded Plasma Cleaner to make hydrophilic a critical raw material which is naturally hydrophobic. Chief Scientific Officer, Yulia Sapir-Lekhovitser, had this to say about the role of the Harrick Plasma Cleaner at Fesarius: “It’s an amazing machine that does something without which we would need to take an entirely different, and more complicated approach to achieve what we do with the Plasma Cleaner”.

Harrick Plasma is a leading supplier of plasma equipment to the research community. We have been providing quality tabletop plasma devices specifically designed for laboratory and R&D use for over 30 years.